Topics
Latest
AI
Amazon
Image Credits:Century Health / Century Health co-founders Vish Srivastava and Sanjay Hariharan
Apps
Biotech & Health
Climate
Image Credits:Century Health / Century Health co-founders Vish Srivastava and Sanjay Hariharan
Cloud Computing
Commerce
Crypto
enterprisingness
EVs
Fintech
Fundraising
gismo
Gaming
Government & Policy
Hardware
layoff
Media & Entertainment
Meta
Microsoft
Privacy
Robotics
security system
Social
blank space
Startups
TikTok
transfer
Venture
More from TechCrunch
upshot
Startup Battlefield
StrictlyVC
Podcasts
Videos
Partner Content
TechCrunch Brand Studio
Crunchboard
Contact Us
Artificial intelligence can find out of sight signals in data across healthcare , and company like Nvidia are leaning into what this can mean . For model , itannounced two dozen new AI - power toolslast workweek for areas include biotech and drug discovery . And Nvidia is not alone .
Century Healthis a new startup also getting in on the action . It ’s applying AI to clinical data to uncover Modern app for drugs . It ’s working with pharmaceutical companies and research worker , initially at Yale and UC San Diego , to place and market the next breakthrough for diseases , like Alzheimer ’s , that affect 10 of millions of patient role .
The mission is a personal one for Century Health ’s Colorado - founder and CEO , Vish Srivastava . He watched his grandfather ’s Alzheimer ’s get to the point in time where he did n’t recognize Srivastava anymore .
“ That sent me down a rabbit hole , ” said Srivastava , whose background is in health care mathematical product development and datum . “ One of the biggest issue around innovation for raw treatment is efficient access to good patient data . This is now only potential because of productive AI . That data point sat around for decades because it takes manual drive to normalize and extract insight from it . ”
Want to see an NHS doctor ? devise to cough up your data first .
Join us at TechCrunch Sessions: AI
Exhibit at TechCrunch Sessions: AI
The ultimate destination is accelerating entree to treatment , Srivastava said .
“ Drug development is massively expensive , and on average , use up $ 1 billion to $ 2 billion to develop a novel drug , ” he say . “ From the pharma company ’s perspective , when their drug is now O.K. , the mission is to get it to patients as rapidly as possible . For us , that also entail as affordably as potential with access to good actual - world data . ”
Now with $ 2 million pre - seed funding , Century Health will run three to five pilot over the next several month . The goal is to formalise the initial technology that collects the data and , most importantly , to see the impact the sixth sense from those data point sets can play , Srivastava articulate .
He sees these pilot burner as design partnerships and a path to get feedback on the benefits of drugs , for example , which patient subpopulation might be underrepresented . In addition to the validated engineering science , another milepost will be to batten down early revenue from the pilots , which Century Health can leverage to go after another turn of speculation capital .
The investment was led by 2048 Ventures with involution from LifeX , Everywhere , Alumni Ventures and a radical of saint investors , including Datavant founder Travis May and Evidation founder and CEO Christine Lemke .
Alex Iskold , manage spouse of 2048 Ventures , aver in a statement , “ At 2048 Ventures we have a potent dissertation around literal - time information , in healthcare and beyond . Vish and Sanjay have a visual modality to purchase AI and material world patient information to unlock a better feedback grommet and at long last quicker and more effective drug development and commercialization . ”
TC+ Roundup : How to beguile grocery share in the epoch of AI
